Phreesia Inc (PHR)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Phreesia Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 3 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 10.70 $ — 11% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
4 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 19.6% passed
- More than 10% revenue growth is expected for the coming year 4.5% failed
- Share count grows by less than 3% a year 5.5% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 28.6% failed
- Gross margin at 40% or higher and without meaningful erosion 67.9% passed
- Goodwill from acquisitions does not grow faster than revenue 25.6% failed
- Net debt below twice EBITDA 1.0 x EBITDA passed
- Operating cash flow covers the profits of the last three years 272 m passed
- Return on capital at 15% or higher, or up versus two years ago -1.4% failed
- Insiders hold at least 10% or are net buyers 4.3% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 30.3% above the current price.
- Consensus
- Strong Sell
- Analyst Ratings
- 15
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 01/31/2027 | 1.33 | 1.12 – 1.51 | 515 | 2.8% | 10 |
| 01/31/2028 | 1.61 | 1.42 – 1.95 | 538 | 20.8% | 9 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.10 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2025: Q1 | -0.11 | – | 110 | 15.40 | -5.80 | 16 | 9 |
| 2025: Q2 | -0.07 | – | 116 | 14.50 | -3.40 | 15 | 8 |
| 2025: Q3 | 0.01 | – | 117 | 14.80 | 0.60 | 15 | 13 |
| 2025: Q4 | 0.07 | – | 120 | 12.70 | 3.50 | 16 | 12 |
| 2026: Q1 | 0.02 | – | 127 | 15.90 | 1.00 | 34 | 31 |
| 2026: Q2 | 0.05 | – | 131 | 12.90 | 2.30 | 22 | 17 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2018 | 80 | -15 | -18 | -11.82 | -11 | -168 | 57 |
| 2019 | 100 | -9 | -15 | -8.16 | -2 | -211 | 59 |
| 2020 | 125 | -15 | -20 | -1.00 | 1 | 102 | 159 |
| 2021 | 149 | -26 | -27 | -0.69 | 3 | 263 | 327 |
| 2022 | 213 | -117 | -118 | -2.37 | -75 | 417 | 494 |
| 2023 | 281 | -177 | -176 | -3.36 | -90 | 288 | 370 |
| 2024 | 356 | -136 | -137 | -2.51 | -32 | 251 | 370 |
| 2025 | 420 | -58 | -59 | -1.02 | 32 | 265 | 388 |
| 2026 | 481 | -7 | 2 | 0.04 | 79 | 337 | 664 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Phreesia, Inc. bietet eine integrierte SaaS-basierte Software- und Zahlungsplattform für die Gesundheitsbranche in den USA und Kanada an.
| Employees | 1,789 |
|---|---|
| Headquarters | Wilmington, DE |
| Address | 1521 Concord Pike, 19803 Wilmington, United States |
| Phone | 888 654 7473 |
| Website | phreesia.com |
| IPO Date | 18. Jul 2019 |
| ISIN | US71944F1066 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Chaim Indig | Co-Founder, CEO & Director | 1979 |
| Evan Roberts | Co-Founder & President of Provider Solutions | 1980 |
| Balaji Gandhi | Chief Financial Officer | 1975 |
| Allison C. Hoffman J.D. | General Counsel & Secretary | 1971 |
| David Linetsky | President of Network Solutions | 1981 |
| Yvonne Hui | Senior VP & Chief Accounting Officer | 1982 |
| Jack Callahan | Chief Technology Officer | – |
| Briana Kearney | Vice President of Marketing | – |
| Amy Beth VanDuyn | Senior Vice President of Human Resources | 1974 |
| Nick Kemske | Chief Information Security Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 16. Jul 2026 | Hui Yvonne | Principal Accounting Officer | Sell | 1,247 | 10.92 | 13,617 |
| 15. Jul 2026 | Linetsky David | President, Network Solutions | Other | 69 | 10.76 | 742 |
| 15. Jul 2026 | Hui Yvonne | Principal Accounting Officer | Other | 937 | 10.76 | 10,082 |
| 14. Jul 2026 | Egbuonu-Davis Lisa | Director | Sell | 536 | 10.70 | 5,735 |
| 20. Apr 2026 | Allison C Hoffman | General Counsel | Sell | 6,176 | 9.06 | 55,955 |
| 17. Apr 2026 | Yvonne Hui | Insider | Sell | 1,327 | 9.28 | 12,315 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.